Heart failure & cardiomyopathies
Prognosis of Early-Stage Heart Failure with Preserved Ejection Fraction (HFpEF) in the Community-Dwelling Elderly: The Northern Shanghai Study
Authors' conclusion
Compared with those with HFpEF stage 0, patients with HFpEF, whether in stage B or C, exhibit significantly higher cardiovascular and all-cause mortality in the elderly.
Study context
- Population
- Community-dwelling individuals aged over 65 from northern Shanghai1,623 included
- Participants
- 1,789 individuals
- Exposure
- HFpEF stages A, B and C vs stage 0
- Outcome
- MACE, all-cause death and CV death
- Follow-up
- Mean 7.10 ± 1.27 years
Methodological detailscommunity-based
- Community-based
Main finding
As reported in the abstract
MACE
Each group vs HFpEF stage 0Hazard ratio (95% CI)P value
HFpEF stage A
2.97(1.13–7.82)
P < 0.05HFpEF stage B
2.69(1.09–6.64)
P < 0.05HFpEF stage C
4.86(1.88–12.59)
P < 0.01- Stages A, B and C had more MACE than stage 0
- P < 0.01
- Stage C had significantly higher CV death ratio
- P < 0.001
- Stage C had significantly higher all-cause death ratio
- P < 0.01
Observational data: associations, not effects.
Original publication
Prognosis of Early-Stage HFpEF in the Community-Dwelling Elderly: The Northern Shanghai Study. ESC Heart Fail. Published 12 September 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →